UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

UiPath (NYSE:PATH) executives used the company’s latest earnings call question-and-answer session to emphasize what they ...

Continuing its evolution from a robotic process automation provider to an agentic artificial intelligence platform, UiPath Inc. today unveiled a series of new capabilities designed to simplify the ...

UiPath faces significant challenges, and its stock price reflects them. Leadership changes and solid financial metrics could pave the way to a recovery. The stock price is down 54% from recent highs, ...

UiPath Inc. raised its full-year revenue outlook after cruising past Wall Street’s expectations and swinging to a profit in its latest quarterly results, powered by momentum in its artificial ...

UiPath Inc. is rated a strong buy, with a price target near $18, following a 30% sell-off driven by AI-related sector fears. PATH's robust AI-driven automation platform, strong earnings beats, and 16% ...

I recommend rotating into catalyst-driven small- and mid-cap stocks like UiPath to protect capital as the S&P 500 hits new highs. UiPath stands out with improving sales momentum, profitability, and a ...

UiPath, Inc. (NYSE: PATH), a global leader in agentic automation, today announced financial results for its fourth quarter and full year fiscal 2026 ended January 31, 2026.

Chris Ashley, Director of BD & Strategy at UiPath, doesn't mince words about where most organizations actually stand on data ...